Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for John Maraganore. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at John Maraganore har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AGIO / Agios Pharmaceuticals, Inc. Director 28.528
US:PROK / ProKidney Corp. Director 0
US:KYMR / Kymera Therapeutics, Inc. Director 24.000
US:ALNY / Alnylam Pharmaceuticals, Inc. Chief Executive Officer, Director 227.663
US:BEAM / Beam Therapeutics Inc. Director 13.133
US:BLUE / bluebird bio, Inc. Director 0
US:RGLS / Regulus Therapeutics Inc. Director, 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af John Maraganore. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AGIO / Agios Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AGIO / Agios Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-12-16 AGIO MARAGANORE JOHN 1.806 110,7500 1.806 110,7500 200.014 29 135.0100 43.814 21,91
2014-06-23 AGIO MARAGANORE JOHN 2.300 43,9800 2.300 43,9800 101.154
2014-04-29 AGIO MARAGANORE JOHN 2.250 44,0000 2.250 44,0000 99.000
2013-07-24 AGIO MARAGANORE JOHN 8.333 18,0000 8.333 18,0000 149.994

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Insidersalg AGIO / Agios Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AGIO / Agios Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2018-09-12 AGIO MARAGANORE JOHN 14.162 71,7400 14.162 71,7400 1.015.982 362 33.5000 -541.554 -53,30
2018-09-12 AGIO MARAGANORE JOHN 0 0
2018-09-11 AGIO MARAGANORE JOHN 11.155 72,5200 11.155 72,5200 808.961
2018-09-11 AGIO MARAGANORE JOHN 2.400 73,8200 2.400 73,8200 177.168

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Insiderkøb BEAM / Beam Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AGIO / Agios Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BEAM / Beam Therapeutics Inc. Insider Trades
Insidersalg BEAM / Beam Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AGIO / Agios Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BEAM / Beam Therapeutics Inc. Insider Trades
Insiderkøb KYMR / Kymera Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AGIO / Agios Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KYMR / Kymera Therapeutics, Inc. Insider Trades
Insidersalg KYMR / Kymera Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AGIO / Agios Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

KYMR / Kymera Therapeutics, Inc. Insider Trades
Insiderkøb PROK / ProKidney Corp. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AGIO / Agios Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PROK / ProKidney Corp. Insider Trades
Insidersalg PROK / ProKidney Corp. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AGIO / Agios Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PROK / ProKidney Corp. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af John Maraganore som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-02-03 2022-09-20 5 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
G - Gift -1.500 28.528 -5,00
2022-07-13 3 PROK PROKIDNEY CORP.
No securities owned.
0
2022-05-24 2022-05-20 4 AGIO AGIOS PHARMACEUTICALS, INC.
Restricted stock unit
M - Exercise -1.585 0 -100,00
2022-05-24 2022-05-20 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
M - Exercise 1.585 30.028 5,57
2022-01-19 2022-01-18 4 KYMR Kymera Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 24.000 24.000
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -319 227.663 -0,14 186,02 -59.340 42.349.871
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2 227.982 0,00 190,50 -381 43.430.571
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.315 227.984 -2,70 189,13 -1.194.356 43.118.614
2021-12-23 2021-12-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.167 234.299 6,44
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -839 51.661 -1,60
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.036 73.964 -1,38
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1.124 63.876 -1,73
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.368 22.632 -9,47
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.368 220.132 1,09 42,22 99.977 9.293.973
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 839 217.764 0,39 119,13 99.950 25.942.225
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.124 216.925 0,52 88,95 99.980 19.295.479
2021-12-14 2021-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.036 215.801 0,48 96,45 99.922 20.814.006
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -33.978 0 -100,00
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -670 214.765 -0,31 174,34 -116.808 37.442.130
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -683 215.435 -0,32 173,25 -118.330 37.324.114
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14.518 216.118 -6,29 172,22 -2.500.290 37.219.842
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.742 230.636 -3,25 171,35 -1.326.592 39.519.479
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.365 238.378 -4,17 170,36 -1.765.781 40.610.076
2021-11-12 2021-11-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33.978 248.743 15,82 7,10 241.244 1.766.075
2021-11-08 2021-11-05 4 BEAM Beam Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 13.133 13.133
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -33.979 33.978 -50,00
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -214 214.765 -0,10 201,55 -43.132 43.285.886
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.828 214.979 -1,75 200,84 -768.816 43.176.382
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23.336 218.807 -9,64 199,92 -4.665.333 43.743.895
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.160 242.143 -1,69 198,93 -827.549 48.169.507
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.441 246.303 -0,98 198,02 -483.367 48.772.920
2021-08-16 2021-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33.979 248.744 15,82 7,10 241.251 1.766.082
2021-06-02 2021-05-28 4 AGIO AGIOS PHARMACEUTICALS, INC.
Restricted stock units
M - Exercise -1.686 0 -100,00
2021-06-02 2021-05-28 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
M - Exercise 1.686 28.443 6,30
2021-06-02 2021-02-04 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
G - Gift -3.415 26.757 -11,32
2021-05-24 2021-05-20 4 AGIO AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy)
A - Award 8.888 8.888
2021-05-24 2021-05-20 4 AGIO AGIOS PHARMACEUTICALS, INC.
Restricted stock unit
A - Award 1.585 1.585
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -33.979 67.957 -33,33
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.023 214.765 -0,47 134,37 -137.461 28.857.973
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.624 215.788 -0,75 133,56 -216.901 28.820.645
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.481 217.412 -1,58 132,32 -460.606 28.767.956
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11.203 220.893 -4,83 131,18 -1.469.610 28.976.744
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.121 232.096 -3,78 130,34 -1.188.831 30.251.393
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.512 241.217 -1,84 129,32 -583.492 31.194.182
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.015 245.729 -1,21 128,30 -386.824 31.527.031
2021-05-17 2021-05-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33.979 248.744 15,82 7,10 241.251 1.766.082
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -270 214.765 -0,13 134,62 -36.347 28.911.578
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -7.237 215.035 -3,26 131,75 -953.475 28.330.861
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 16.236 222.272 7,88
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -33.979 101.936 -25,00
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -599 206.036 -0,29 154,59 -92.599 31.851.105
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -431 206.635 -0,21 153,33 -66.085 31.683.345
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.138 207.066 -0,55 152,46 -173.499 31.569.282
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.415 208.204 -0,68 151,31 -214.104 31.503.347
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.054 209.619 -0,97 150,22 -308.552 31.488.966
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.364 211.673 -0,64 148,96 -203.181 31.530.810
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.375 213.037 -2,01 148,00 -647.500 31.529.476
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.097 217.412 -2,73 146,98 -896.137 31.955.216
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.376 223.509 -4,03 146,13 -1.370.115 32.661.370
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.129 232.885 -2,56 145,15 -889.624 33.803.258
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.001 239.014 -0,42 143,88 -144.024 34.389.334
2021-02-26 2021-02-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33.979 240.015 16,49 7,10 241.251 1.704.106
2021-02-26 2021-02-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 79.998 79.998
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -307 206.036 -0,15 151,94 -46.645 31.304.492
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5.412 206.343 -2,56 156,00 -844.272 32.189.508
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 17.504 52.500 50,02
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.166 211.755 7,17
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -34.765 0 -100,00
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -102 197.589 -0,05 126,62 -12.915 25.018.719
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.187 197.691 -4,90 125,35 -1.276.940 24.780.567
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.489 207.878 -2,57 124,49 -683.326 25.878.732
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.987 213.367 -8,17 123,55 -2.345.844 26.361.493
2020-11-20 2020-11-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 34.765 232.354 17,59 9,14 317.752 2.123.716
2020-08-21 2020-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -34.765 34.765 -50,00
2020-08-21 2020-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.542 197.589 -4,14 136,86 -1.169.058 27.042.031
2020-08-21 2020-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21.448 206.131 -9,42 136,07 -2.918.429 28.048.245
2020-08-21 2020-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.775 227.579 -2,06 135,09 -645.055 30.743.647
2020-08-21 2020-08-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 34.765 232.354 17,59 9,14 317.752 2.123.716
2020-06-01 2020-05-29 4 AGIO AGIOS PHARMACEUTICALS, INC.
Restricted stock units
M - Exercise -1.878 0 -100,00
2020-06-01 2020-05-29 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
M - Exercise 1.878 30.172 6,64
2020-06-01 2020-05-28 4 AGIO AGIOS PHARMACEUTICALS, INC.
Restricted stock units
A - Award 1.686 1.686
2020-06-01 2020-05-28 4 AGIO AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy)
A - Award 8.096 8.096
2020-05-22 2020-05-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -34.765 69.530 -33,33
2020-05-22 2020-05-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.013 197.589 -2,47 144,33 -723.526 28.518.020
2020-05-22 2020-05-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16.315 202.602 -7,45 143,46 -2.340.550 29.065.283
2020-05-22 2020-05-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13.437 218.917 -5,78 142,51 -1.914.907 31.197.862
2020-05-22 2020-05-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 34.765 232.354 17,59 9,14 317.752 2.123.716
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -256 197.589 -0,13 106,27 -27.205 20.997.783
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.315 197.845 -3,09 104,75 -661.496 20.724.264
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 14.167 204.160 7,46
2020-02-28 2020-02-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 88.240 88.240
2020-02-28 2020-02-14 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
G - Gift -1.915 28.294 -6,34
2020-02-28 2020-02-14 4 AGIO AGIOS PHARMACEUTICALS, INC.
Common stock
G - Gift -2.400 30.209 -7,36
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -34.765 104.295 -25,00
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -502 189.993 -0,26 133,42 -66.977 25.348.866
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.065 190.495 -8,66 132,81 -2.399.213 25.299.641
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6.887 208.560 -3,20 131,61 -906.398 27.448.582
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.053 215.447 -2,29 131,07 -662.297 28.238.638
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.586 220.500 -0,71 129,33 -205.117 28.517.265
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.672 222.086 -1,19 128,62 -343.673 28.564.701
2020-02-21 2020-02-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 34.765 224.758 18,30 9,14 317.752 2.054.288
2019-12-26 2019-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 17.498 34.996 100,00
2019-11-26 2019-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 17.498 17.498
2019-10-16 2019-10-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -49.456 0 -100,00
2019-10-16 2019-10-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.870 189.993 -0,97 80,31 -150.180 15.258.338
2019-10-16 2019-10-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26.754 191.863 -12,24 79,80 -2.134.969 15.310.667
2019-10-16 2019-10-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20.832 218.617 -8,70 78,92 -1.644.061 17.253.254
2019-10-16 2019-10-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 49.456 239.449 26,03 16,43 812.562 3.934.147
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 25.000 33,33
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 16.250 65.000 33,33
2019-08-07 2019-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 34 3.133 1,10
2019-06-14 2019-06-12 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
G - Gift -5.000 32.609 -13,29
2019-06-07 2019-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 18.750 50,00
2019-05-31 2019-05-31 4 AGIO AGIOS PHARMACEUTICALS INC
Restricted stock units
M - Exercise -1.400 0 -100,00
2019-05-31 2019-05-31 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
M - Exercise 1.400 37.609 3,87
2019-05-31 2019-05-29 4 AGIO AGIOS PHARMACEUTICALS INC
Restricted stock units
A - Award 1.878 1.878
2019-05-31 2019-05-29 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 8.919 8.919
2019-05-17 2019-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -49.457 49.456 -50,00
2019-05-17 2019-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -49.457 189.993 -20,65 70,00 -3.461.990 13.299.510
2019-05-17 2019-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 49.457 239.450 26,03 16,43 812.579 3.934.164
2019-05-17 2019-04-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 61 3.099 2,01
2019-03-01 2019-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 85.000 85.000
2018-11-26 2018-11-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -98.636 0 -100,00
2018-11-26 2018-11-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -59.940 189.993 -23,98 72,68 -4.356.439 13.808.691
2018-11-26 2018-11-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 98.636 249.933 65,19 21,35 2.105.879 5.336.070
2018-11-26 2018-10-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 17 3.038 0,56
2018-11-06 2018-09-12 4/A AGIO AGIOS PHARMACEUTICALS INC
Common stock
S - Sale 0 36.209 0,00
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6.250 12.500 100,00
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 16.250 48.750 50,00
2018-09-13 2018-09-12 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
S - Sale -14.162 22.047 -39,11 71,74 -1.015.982 1.581.652
2018-09-13 2018-09-11 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
S - Sale -2.400 36.209 -6,22 73,82 -177.168 2.672.948
2018-09-13 2018-09-11 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
S - Sale -11.155 38.609 -22,42 72,52 -808.961 2.799.925
2018-08-23 2018-08-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 16.250 32.500 100,00
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2013 (right to buy)
A - Award 25.000 75.000 50,00
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2014 (right to buy)
A - Award 25.000 75.000 50,00
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -50.000 98.636 -33,64
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.400 151.297 -0,92 106,25 -148.750 16.075.306
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -34.995 152.697 -18,64 105,83 -3.703.521 16.159.924
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.758 187.692 -3,97 104,83 -813.271 19.675.752
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.847 195.450 -1,93 103,69 -398.895 20.266.210
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.000 199.297 -0,99 102,51 -205.020 20.429.935
2018-07-27 2018-07-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 50.000 201.297 33,05 21,35 1.067.500 4.297.691
2018-07-27 2018-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 31 3.021 1,04
2018-07-27 2018-04-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 30 2.990 1,01
2018-06-04 2018-05-31 4 AGIO AGIOS PHARMACEUTICALS INC
Restricted stock units
A - Award 1.400 1.400
2018-06-04 2018-05-31 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 5.700 5.700
2018-03-05 2018-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 52.500 52.500
2017-12-21 2017-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2016 (right to buy)
A - Award 6.250 6.250
2017-12-21 2017-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise 1.587 148.413 1,08
2017-12-21 2017-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.587 151.297 1,06 63,00 99.981 9.531.711
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -73.415 0 -100,00
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.683 149.710 -1,76 132,73 -356.115 19.871.008
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20.433 152.393 -11,82 131,82 -2.693.478 20.088.445
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.036 172.826 -12,65 130,88 -3.276.712 22.619.467
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25.263 197.862 -11,32 129,97 -3.283.432 25.716.124
2017-11-24 2017-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 73.415 223.125 49,04 31,39 2.304.497 7.003.894
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -74.000 73.415 -50,20
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -600 149.710 -0,40 130,22 -78.131 19.494.937
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.850 150.310 -3,13 129,57 -628.414 19.475.667
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.571 155.160 -6,38 128,48 -1.358.204 19.935.577
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.120 165.731 -4,12 127,54 -908.085 21.137.332
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -28.399 172.851 -14,11 126,60 -3.595.399 21.883.455
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -22.460 201.250 -10,04 125,54 -2.819.718 25.265.730
2017-11-17 2017-11-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 74.000 223.710 49,43 31,39 2.322.860 7.022.257
2017-11-08 2017-11-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 16.250 16.250
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
A - Award 25.000 25.000
2017-09-18 2017-09-14 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise 18.868 0 -100,00
2017-09-18 2017-09-14 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -600 5.843 -9,31 131,82 -79.090 770.205
2017-09-18 2017-09-14 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -18.268 6.443 -73,93 131,19 -2.396.643 845.280
2017-09-18 2017-09-14 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 18.868 24.711 322,92 2,09 39.434 51.646
2017-08-28 2017-08-24 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise 13.839 18.868 275,18
2017-08-28 2017-08-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -6.385 8.597 -42,62 96,32 -615.019 828.085
2017-08-28 2017-08-24 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -4.700 14.982 -23,88 95,13 -447.089 1.425.167
2017-08-28 2017-08-24 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 13.839 19.682 236,85 2,09 28.924 41.135
2017-08-28 2017-08-02 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -2.754 5.843 -32,03 96,74 -266.425 565.258
2017-07-11 2017-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 25.000 50.000 100,00
2017-06-15 2017-06-13 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 8.000 8.000
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 4.000 4.000
2017-06-12 2017-06-08 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.000 5.843 20,65
2017-03-06 2017-03-03 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -12.917 0 -100,00
2017-03-06 2017-03-03 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
M - Exercise -922 0 -100,00
2017-03-06 2017-03-03 4 BLUE bluebird bio, Inc.
Common Stock
S - Sale -13.839 4.843 -74,08 85,02 -1.176.646 411.771
2017-03-06 2017-03-03 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 12.917 18.682 224,06 5,50 71.049 102.758
2017-03-06 2017-03-03 4 BLUE bluebird bio, Inc.
Common Stock
M - Exercise 922 5.765 19,04 0,95 874 5.468
2017-01-23 2016-12-20 4 BLUE bluebird bio, Inc.
Common Stock
G - Gift -1.450 4.843 -23,04
2017-01-06 2017-01-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -1.340 144.641 -0,92
2017-01-06 2017-01-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1.340 149.710 0,90 18,66 25.004 2.793.589
2016-12-22 2016-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25.000 25.000
2016-12-14 2016-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -30.151 0 -100,00
2016-12-14 2016-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes -22.710 148.370 -13,27 42,61 -967.673 6.322.046
2016-12-14 2016-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30.151 171.080 21,39 22,75 685.935 3.892.070
2016-10-14 2016-10-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -4.019 145.981 -2,68
2016-10-14 2016-10-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -3.521 135.915 -2,53
2016-10-14 2016-10-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.019 140.929 2,94 18,66 74.995 2.629.735
2016-10-14 2016-10-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3.521 136.910 2,64 7,10 24.999 972.061
2016-07-21 2016-07-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -15.075 30.151 -33,33
2016-07-21 2016-07-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.418 133.389 -1,78 66,00 -159.586 8.803.581
2016-07-21 2016-07-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.057 135.807 -8,15 65,56 -790.430 8.903.208
2016-07-21 2016-07-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -600 147.864 -0,40 64,29 -38.575 9.506.428
2016-07-21 2016-07-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.075 148.464 11,30 22,75 342.956 3.377.556
2016-07-21 2016-07-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -15.076 45.226 -25,00
2016-07-21 2016-07-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.505 133.389 -1,12 64,56 -97.159 8.611.274
2016-07-21 2016-07-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13.571 134.894 -9,14 63,73 -864.839 8.596.390
2016-07-21 2016-07-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.076 148.465 11,30 22,75 342.979 3.377.579
2016-06-23 2016-06-21 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 8.000 41.125 24,15
2016-06-03 2016-06-02 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 4.000 4.000
2016-06-03 2016-06-02 4 BLUE bluebird bio, Inc.
Common Stock
A - Award 1.000 1.000
2016-04-21 2016-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X 15.075 60.302 33,33
2016-04-21 2016-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.405 133.389 -1,77 68,24 -164.128 9.103.052
2016-04-21 2016-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12.670 135.794 -8,53 67,38 -853.645 9.149.161
2016-04-21 2016-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.075 148.464 11,30 22,75 342.956 3.377.556
2016-04-21 2016-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X 15.076 75.377 25,00
2016-04-21 2016-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 133.389 -0,22 68,71 -20.612 9.164.718
2016-04-21 2016-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.405 133.689 -3,89 68,00 -367.555 9.091.226
2016-04-21 2016-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.371 139.094 -6,31 67,02 -628.032 9.321.899
2016-04-21 2016-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.076 148.465 11,30 22,75 342.979 3.377.579
2016-02-03 2016-02-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 25.000 25.000
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -15.076 90.453 -14,29
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -325 133.389 -0,24 74,61 -24.249 9.952.567
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.865 133.714 -1,38 73,77 -137.577 9.863.774
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -400 135.579 -0,29 72,51 -29.005 9.831.172
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.136 135.979 -0,83 71,79 -81.548 9.761.307
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -930 137.115 -0,67 70,43 -65.498 9.656.776
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.114 138.045 -1,51 69,40 -146.704 9.579.798
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.406 140.159 -3,05 68,35 -301.155 9.580.008
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.700 144.565 -1,83 67,39 -181.961 9.742.669
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.200 147.265 -0,81 66,28 -79.537 9.760.842
2016-01-21 2016-01-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.076 148.465 11,30 22,75 342.979 3.377.579
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -15.076 105.529 -12,50
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 133.389 -0,15 78,04 -15.608 10.409.678
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -200 133.589 -0,15 76,95 -15.390 10.279.674
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.245 133.789 -1,65 75,97 -170.550 10.163.803
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.400 136.034 -2,44 75,01 -255.050 10.204.550
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.112 139.434 -3,54 74,14 -378.993 10.337.344
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.281 144.546 -0,88 73,03 -93.546 10.555.587
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 145.827 -0,55 71,81 -57.447 10.471.662
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.838 146.627 -1,24 70,95 -130.401 10.402.760
2016-01-21 2016-01-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15.076 148.465 11,30 22,75 342.979 3.377.579
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 65.000 65.000
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -58.689 0 -100,00
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -700 133.389 -0,52 106,60 -74.622 14.219.601
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16.984 134.089 -11,24 106,02 -1.800.596 14.215.740
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20.238 151.073 -11,81 105,16 -2.128.192 15.886.565
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10.784 171.311 -5,92 104,00 -1.121.541 17.816.430
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9.983 182.095 -5,20 103,15 -1.029.764 18.783.427
2015-12-04 2015-12-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 58.689 192.078 44,00 13,12 770.000 2.520.063
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -10.564 139.436 -7,04
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -58.690 58.689 -50,00
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8.070 133.389 -5,70 103,97 -839.023 13.868.201
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23.483 141.459 -14,24 103,13 -2.421.832 14.588.851
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -27.137 164.942 -14,13 102,34 -2.777.078 16.879.422
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10.564 192.079 5,82 7,10 75.004 1.363.761
2015-11-20 2015-11-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 58.690 181.515 47,78 13,12 770.013 2.381.477
2015-06-25 2015-06-23 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 10.625 33.125 47,22
2015-06-17 2015-06-15 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
G - Gift -410 49.764 -0,82
2015-06-08 2015-06-04 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2015-05-05 2015-05-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2015-04-30 2015-04-28 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
G - Gift -515 50.174 -1,02
2015-01-28 2015-01-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 10.000 122.825 8,86 95,00 950.000 11.668.375
2014-12-22 2014-12-19 4 BLUE bluebird bio, Inc.
Common Stock
P - Purchase 2.352 5.293 79,97 85,00 199.920 449.905
2014-12-18 2014-12-16 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 1.806 50.689 3,69 110,75 200.014 5.613.807
2014-12-16 2014-12-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -8.205 139.060 -5,57
2014-12-16 2014-12-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8.205 112.825 7,84 9,14 74.994 1.031.220
2014-12-16 2014-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance-Based Stock Option (Right to Buy)
A - Award 25.000 25.000
2014-09-19 2014-09-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -56.834 0 -100,00
2014-09-19 2014-09-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37.872 104.620 -26,58 79,23 -3.000.549 8.288.907
2014-09-19 2014-09-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18.962 142.492 -11,74 78,12 -1.481.274 11.131.190
2014-09-19 2014-09-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 56.834 161.454 54,32 7,47 424.550 1.206.061
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -56.834 56.834 -50,00
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -400 104.620 -0,38 78,10 -31.242 8.171.282
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15.849 105.020 -13,11 77,71 -1.231.696 8.161.566
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23.286 120.869 -16,15 76,54 -1.782.317 9.251.350
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -13.899 144.155 -8,79 75,65 -1.051.393 10.904.634
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.400 158.054 -2,11 74,74 -254.102 11.812.324
2014-09-19 2014-09-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 56.834 161.454 54,32 7,47 424.550 1.206.061
2014-09-19 2014-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -1.700 104.620 -1,60
2014-07-14 2014-07-14 4 BLUE bluebird bio, Inc.
Common Stock
P - Purchase 2.941 2.941 34,00 99.994 99.994
2014-06-27 2014-06-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -56.834 113.668 -33,33
2014-06-27 2014-06-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.800 106.320 -1,66 66,61 -119.901 7.082.156
2014-06-27 2014-06-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5.570 108.120 -4,90 65,50 -364.811 7.081.395
2014-06-27 2014-06-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -49.464 113.690 -30,32 64,66 -3.198.214 7.350.900
2014-06-27 2014-06-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 56.834 163.154 53,46 7,47 424.550 1.218.760
2014-06-27 2014-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -56.834 170.502 -25,00
2014-06-27 2014-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -32.846 106.320 -23,60 66,29 -2.177.266 7.047.644
2014-06-27 2014-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23.988 139.166 -14,70 65,86 -1.579.905 9.165.793
2014-06-27 2014-06-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 56.834 163.154 53,46 7,47 424.550 1.218.760
2014-06-24 2014-06-23 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 2.300 48.883 4,94 43,98 101.154 2.149.874
2014-06-12 2014-06-11 4 BLUE bluebird bio, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2014-06-05 2014-05-30 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 12.500 22.500 125,00
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X 22.664 227.336 11,07
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X 34.170 0 -100,00
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.926 106.320 -2,68 56,71 -165.940 6.029.630
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -53.908 109.246 -33,04 56,06 -3.022.287 6.124.746
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 22.664 163.154 16,13 7,47 169.300 1.218.760
2014-05-16 2014-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 34.170 140.490 32,14 6,78 231.673 952.522
2014-05-16 2014-05-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X 56.834 34.170 -250,77
2014-05-16 2014-05-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.500 106.320 -15,50 57,64 -1.124.076 6.128.806
2014-05-16 2014-05-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37.334 125.820 -22,88 57,20 -2.135.639 7.197.357
2014-05-16 2014-05-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 56.834 163.154 53,46 6,78 385.335 1.106.184
2014-04-30 2014-04-29 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 2.250 46.583 5,08 44,00 99.000 2.049.652
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -3.185 147.415 -2,11
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -4.684 148.636 -3,06
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -6.087 98.913 -5,80
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2.735 147.265 -1,82
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -4.395 120.605 -3,52
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7.621 117.379 -6,10
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6.087 106.320 6,07 16,43 100.009 1.746.838
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.684 100.233 4,90 21,35 100.003 2.139.975
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3.185 95.549 3,45 31,39 99.977 2.999.283
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.395 92.364 5,00 22,75 99.986 2.101.281
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7.621 87.969 9,48 13,12 99.988 1.154.153
2014-04-15 2014-04-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2.735 80.348 3,52 9,14 24.998 734.381
2014-04-03 2013-07-24 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 8.333 44.333 23,15 18,00 149.994 797.994
2014-02-04 2014-02-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -46.331 91.004 -33,74
2014-02-04 2014-02-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 46.331 77.613 148,11 6,78 314.124 526.216
2013-12-18 2013-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 150.000 150.000
2013-12-06 2013-12-04 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2013-10-15 2013-10-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise -12.665 46.331 -21,47
2013-10-15 2013-10-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12.665 31.282 68,03 6,78 85.869 212.092
2013-09-24 2013-09-11 4/A ALKS ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -45.263 0 -100,00
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -13.684 0 -100,00
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.100 18.617 -5,58 57,02 -62.726 1.061.608
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.800 19.717 -16,16 56,33 -214.070 1.110.741
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -54.047 23.517 -69,68 55,41 -2.994.728 1.303.070
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 45.263 77.564 140,13 0,95 43.000 73.686
2013-09-12 2013-09-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 13.684 32.301 73,50 0,95 13.000 30.686
2013-08-16 2013-08-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -60.000 45.263 -57,00
2013-08-16 2013-08-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -40.237 18.617 -68,37 49,06 -1.974.188 913.424
2013-08-16 2013-08-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19.763 58.854 -25,14 48,77 -963.938 2.870.598
2013-08-16 2013-08-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 60.000 78.617 322,29 0,95 57.000 74.686
2013-07-23 3 AGIO AGIOS PHARMACEUTICALS INC
Common Stock
36.000
2013-07-12 2013-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X -60.000 13.684 -81,43
2013-07-12 2013-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -60.000 18.617 -76,32 37,11 -2.226.822 690.946
2013-07-12 2013-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 60.000 78.617 322,29 0,95 57.000 74.686
2013-02-28 2013-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -28.503 18.617 -60,49 23,50 -669.900 437.552
2013-02-28 2013-02-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -30.000 47.120 -38,90 23,47 -704.019 1.105.779
2012-12-21 2012-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 150.000 150.000
2012-12-21 2012-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -4.515 0 -100,00
2012-12-21 2012-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -14.102 0 -100,00
2012-12-21 2012-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 14.102 77.120 22,38 0,48 6.698 36.632
2012-12-21 2012-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4.515 63.018 7,72 0,48 2.145 29.934
2012-10-11 2012-10-10 4 RGLS Regulus Therapeutics Inc.
Series A Preferred Stock
C - Conversion -6.150.500 0 -100,00
2012-10-11 2012-10-10 4 RGLS Regulus Therapeutics Inc.
Common Stock
C - Conversion 6.150.500 6.150.500
2012-02-23 2012-02-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 5.581 58.503 10,55 10,75 59.996 628.907
2011-10-13 2011-10-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase X 1.480 48.980 3,12 6,75 9.989 330.581
2011-10-13 2011-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift -2.500 47.500 -5,00
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)